Click for best price
Rheumatology Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Rheumatology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatology Drugs. This report contains market size and forecasts of Rheumatology Drugs in global, including the following market information:
Global Rheumatology Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Rheumatology Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Disease Modifying Anti-rheumatic Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Rheumatology Drugs include Takeda Pharmaceutical, Sanofi, Genentech, Novartis, Janssen Biotech, Amgen, AbbVie, Pfizer and Bristol-Myers Squibb Company, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rheumatology Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatology Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Rheumatology Drugs Market Segment Percentages, by Type, 2022 (%)
Disease Modifying Anti-rheumatic Drugs
Nonsteroidal Anti-inflammatory Drugs
Corticosteroids
Uric Acid Drugs
Others
Global Rheumatology Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Rheumatology Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Rheumatology Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Rheumatology Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rheumatology Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Rheumatology Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda Pharmaceutical
Sanofi
Genentech
Novartis
Janssen Biotech
Amgen
AbbVie
Pfizer
Bristol-Myers Squibb Company
Merck & Co.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rheumatology Drugs, market overview.
Chapter 2: Global Rheumatology Drugs market size in revenue.
Chapter 3: Detailed analysis of Rheumatology Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rheumatology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Rheumatology Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Rheumatology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rheumatology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rheumatology Drugs Overall Market Size
2.1 Global Rheumatology Drugs Market Size: 2022 VS 2029
2.2 Global Rheumatology Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Rheumatology Drugs Players in Global Market
3.2 Top Global Rheumatology Drugs Companies Ranked by Revenue
3.3 Global Rheumatology Drugs Revenue by Companies
3.4 Top 3 and Top 5 Rheumatology Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Rheumatology Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rheumatology Drugs Players in Global Market
3.6.1 List of Global Tier 1 Rheumatology Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Rheumatology Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Rheumatology Drugs Market Size Markets, 2022 & 2029
4.1.2 Disease Modifying Anti-rheumatic Drugs
4.1.3 Nonsteroidal Anti-inflammatory Drugs
4.1.4 Corticosteroids
4.1.5 Uric Acid Drugs
4.1.6 Others
4.2 By Type - Global Rheumatology Drugs Revenue & Forecasts
4.2.1 By Type - Global Rheumatology Drugs Revenue, 2018-2023
4.2.2 By Type - Global Rheumatology Drugs Revenue, 2024-2029
4.2.3 By Type - Global Rheumatology Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rheumatology Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.2 By Application - Global Rheumatology Drugs Revenue & Forecasts
5.2.1 By Application - Global Rheumatology Drugs Revenue, 2018-2023
5.2.2 By Application - Global Rheumatology Drugs Revenue, 2024-2029
5.2.3 By Application - Global Rheumatology Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Rheumatology Drugs Market Size, 2022 & 2029
6.2 By Region - Global Rheumatology Drugs Revenue & Forecasts
6.2.1 By Region - Global Rheumatology Drugs Revenue, 2018-2023
6.2.2 By Region - Global Rheumatology Drugs Revenue, 2024-2029
6.2.3 By Region - Global Rheumatology Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Rheumatology Drugs Revenue, 2018-2029
6.3.2 US Rheumatology Drugs Market Size, 2018-2029
6.3.3 Canada Rheumatology Drugs Market Size, 2018-2029
6.3.4 Mexico Rheumatology Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Rheumatology Drugs Revenue, 2018-2029
6.4.2 Germany Rheumatology Drugs Market Size, 2018-2029
6.4.3 France Rheumatology Drugs Market Size, 2018-2029
6.4.4 U.K. Rheumatology Drugs Market Size, 2018-2029
6.4.5 Italy Rheumatology Drugs Market Size, 2018-2029
6.4.6 Russia Rheumatology Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Rheumatology Drugs Market Size, 2018-2029
6.4.8 Benelux Rheumatology Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Rheumatology Drugs Revenue, 2018-2029
6.5.2 China Rheumatology Drugs Market Size, 2018-2029
6.5.3 Japan Rheumatology Drugs Market Size, 2018-2029
6.5.4 South Korea Rheumatology Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Rheumatology Drugs Market Size, 2018-2029
6.5.6 India Rheumatology Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Rheumatology Drugs Revenue, 2018-2029
6.6.2 Brazil Rheumatology Drugs Market Size, 2018-2029
6.6.3 Argentina Rheumatology Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Rheumatology Drugs Revenue, 2018-2029
6.7.2 Turkey Rheumatology Drugs Market Size, 2018-2029
6.7.3 Israel Rheumatology Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Rheumatology Drugs Market Size, 2018-2029
6.7.5 UAE Rheumatology Drugs Market Size, 2018-2029
7 Rheumatology Drugs Companies Profiles
7.1 Takeda Pharmaceutical
7.1.1 Takeda Pharmaceutical Company Summary
7.1.2 Takeda Pharmaceutical Business Overview
7.1.3 Takeda Pharmaceutical Rheumatology Drugs Major Product Offerings
7.1.4 Takeda Pharmaceutical Rheumatology Drugs Revenue in Global Market (2018-2023)
7.1.5 Takeda Pharmaceutical Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Rheumatology Drugs Major Product Offerings
7.2.4 Sanofi Rheumatology Drugs Revenue in Global Market (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Genentech
7.3.1 Genentech Company Summary
7.3.2 Genentech Business Overview
7.3.3 Genentech Rheumatology Drugs Major Product Offerings
7.3.4 Genentech Rheumatology Drugs Revenue in Global Market (2018-2023)
7.3.5 Genentech Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Rheumatology Drugs Major Product Offerings
7.4.4 Novartis Rheumatology Drugs Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Janssen Biotech
7.5.1 Janssen Biotech Company Summary
7.5.2 Janssen Biotech Business Overview
7.5.3 Janssen Biotech Rheumatology Drugs Major Product Offerings
7.5.4 Janssen Biotech Rheumatology Drugs Revenue in Global Market (2018-2023)
7.5.5 Janssen Biotech Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Rheumatology Drugs Major Product Offerings
7.6.4 Amgen Rheumatology Drugs Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 AbbVie
7.7.1 AbbVie Company Summary
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Rheumatology Drugs Major Product Offerings
7.7.4 AbbVie Rheumatology Drugs Revenue in Global Market (2018-2023)
7.7.5 AbbVie Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Rheumatology Drugs Major Product Offerings
7.8.4 Pfizer Rheumatology Drugs Revenue in Global Market (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Bristol-Myers Squibb Company
7.9.1 Bristol-Myers Squibb Company Company Summary
7.9.2 Bristol-Myers Squibb Company Business Overview
7.9.3 Bristol-Myers Squibb Company Rheumatology Drugs Major Product Offerings
7.9.4 Bristol-Myers Squibb Company Rheumatology Drugs Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.10 Merck & Co.
7.10.1 Merck & Co. Company Summary
7.10.2 Merck & Co. Business Overview
7.10.3 Merck & Co. Rheumatology Drugs Major Product Offerings
7.10.4 Merck & Co. Rheumatology Drugs Revenue in Global Market (2018-2023)
7.10.5 Merck & Co. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Rheumatology Drugs Market Opportunities & Trends in Global Market
Table 2. Rheumatology Drugs Market Drivers in Global Market
Table 3. Rheumatology Drugs Market Restraints in Global Market
Table 4. Key Players of Rheumatology Drugs in Global Market
Table 5. Top Rheumatology Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Rheumatology Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Rheumatology Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Rheumatology Drugs Product Type
Table 9. List of Global Tier 1 Rheumatology Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rheumatology Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Rheumatology Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Rheumatology Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Rheumatology Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Rheumatology Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Rheumatology Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Rheumatology Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Rheumatology Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Rheumatology Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Rheumatology Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Rheumatology Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Rheumatology Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Rheumatology Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Rheumatology Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Rheumatology Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Rheumatology Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Rheumatology Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Rheumatology Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Rheumatology Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Rheumatology Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Takeda Pharmaceutical Company Summary
Table 31. Takeda Pharmaceutical Rheumatology Drugs Product Offerings
Table 32. Takeda Pharmaceutical Rheumatology Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Takeda Pharmaceutical Key News & Latest Developments
Table 34. Sanofi Company Summary
Table 35. Sanofi Rheumatology Drugs Product Offerings
Table 36. Sanofi Rheumatology Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Sanofi Key News & Latest Developments
Table 38. Genentech Company Summary
Table 39. Genentech Rheumatology Drugs Product Offerings
Table 40. Genentech Rheumatology Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Genentech Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Rheumatology Drugs Product Offerings
Table 44. Novartis Rheumatology Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis Key News & Latest Developments
Table 46. Janssen Biotech Company Summary
Table 47. Janssen Biotech Rheumatology Drugs Product Offerings
Table 48. Janssen Biotech Rheumatology Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Janssen Biotech Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Rheumatology Drugs Product Offerings
Table 52. Amgen Rheumatology Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. AbbVie Company Summary
Table 55. AbbVie Rheumatology Drugs Product Offerings
Table 56. AbbVie Rheumatology Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. AbbVie Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Rheumatology Drugs Product Offerings
Table 60. Pfizer Rheumatology Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Company Summary
Table 63. Bristol-Myers Squibb Company Rheumatology Drugs Product Offerings
Table 64. Bristol-Myers Squibb Company Rheumatology Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol-Myers Squibb Company Key News & Latest Developments
Table 66. Merck & Co. Company Summary
Table 67. Merck & Co. Rheumatology Drugs Product Offerings
Table 68. Merck & Co. Rheumatology Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Merck & Co. Key News & Latest Developments
List of Figures
Figure 1. Rheumatology Drugs Segment by Type in 2022
Figure 2. Rheumatology Drugs Segment by Application in 2022
Figure 3. Global Rheumatology Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Rheumatology Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Rheumatology Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rheumatology Drugs Revenue in 2022
Figure 8. By Type - Global Rheumatology Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Rheumatology Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Rheumatology Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Rheumatology Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Rheumatology Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Rheumatology Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Rheumatology Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Rheumatology Drugs Revenue Market Share, 2018-2029
Figure 16. US Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Rheumatology Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Rheumatology Drugs Revenue Market Share, 2018-2029
Figure 28. China Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Rheumatology Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Rheumatology Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Rheumatology Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Takeda Pharmaceutical Rheumatology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sanofi Rheumatology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Genentech Rheumatology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis Rheumatology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Janssen Biotech Rheumatology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Rheumatology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AbbVie Rheumatology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer Rheumatology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol-Myers Squibb Company Rheumatology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Merck & Co. Rheumatology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
